Showing results (61-70 of 330) with videos related to
Sort By:
Pageof 33
Journal of Gastroenterology|February 25, 2014
Diagnostic accuracy for macroscopic classification of nodular hepatocellular carcinoma: comparison of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and angiography-assisted computed tomographyToshifumi Tada, Takashi Kumada, Hidenori Toyoda, et al.Journal of Gastroenterology|March 21, 2015
Accurate and rapid identification of feeding arteries with multidetector-row angiography-assisted computed tomography for transarterial chemoembolization for hepatocellular carcinomaKen Takada, Hidenori Toyoda, Toshifumi Tada, et al.Infectious Diseases and Therapy|April 21, 2021
Comparison of the Prognosis of Decompensated Cirrhosis in Patients with and Without Eradication of Hepatitis C VirusTakashi Kumada, Hidenori Toyoda, Satoshi Yasuda, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 11, 2016
Utility of combined gray-scale and perflubutane contrast-enhanced ultrasound for diagnosing early hepatocellular carcinomas: Comparison of well differentiated and distinctly nodular typesToshifumi Tada, Takashi Kumada, Hidenori Toyoda, et al.Journal of Gastroenterology|November 8, 2014
Long-term prognosis of patients with hepatitis B infection: causes of death and utility of nucleos(t)ide analogue therapyToshifumi Tada, Takashi Kumada, Hidenori Toyoda, et al.Alimentary Pharmacology & Therapeutics|July 27, 2018
Impact of previously cured hepatocellular carcinoma (HCC) on new development of HCC after eradication of hepatitis C infection with non-interferon-based treatmentsHidenori Toyoda, Takashi Kumada, Toshifumi Tada, et al.Plos One|July 28, 2015
Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C VirusYoshihiko Tachi, Takanori Hirai, Hidenori Toyoda, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 11, 2019
Influence of renal dysfunction on dose reduction and virologic efficacy of regimens combining ribavirin and all-oral direct acting antivirals in patients with chronic hepatitis C virus infectionMegumi Nakashima, Hidenori Toyoda, Toshifumi Tada, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 16, 2022
Combined ultrasound and magnetic resonance elastography predict hepatocellular carcinoma after hepatitis C virus eradicationTakashi Kumada, Hidenori Toyoda, Satoshi Yasuda, et al.Alimentary Pharmacology & Therapeutics|June 11, 2020
Impact of the introduction of direct-acting anti-viral drugs on hepatocarcinogenesis: a prospective serial follow-up MRI studyTakashi Kumada, Hidenori Toyoda, Satoshi Yasuda, et al.Pageof 33